Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Vanguard Study: Testing a New Way to Screen for Cancer [NA]
The Vanguard Study is a National Cancer Institute–sponsored cancer screening trial that is currently recruiting to evaluate a new screening …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan [Phase 1]
Phase 1 trial evaluating the safety, adverse events, and pharmacokinetics of Azirkitug alone or in combination with Budigalimab, Bevacizumab…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase 1/1b Study of IAM1363 in HER2 Cancers [Phase 1]
IAM1363 is being studied in a Phase 1/1b trial for HER2-related cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy [Phase 1]
This Phase 1 trial update describes evaluating ropidoxuridine as a radiosensitizer in patients with advanced gastrointestinal cancers underg…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors [Phase 2]
Phase 2 study evaluating futibatinib in combination with a PD-1 antibody-based standard of care for locally advanced unresectable or metasta…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer [Phase 2]
Phase 2 clinical trial update for liposomal irinotinecan with carboplatin or oxaliplatin in esophageal cancer; the study is active but not r…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A clinical trial is enrolling people with and without cancer to collect blood samples and evaluate tests for early cancer detection across m…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) [Phase 1]
Phase 1 study of ADP-A2M4CD8 as monotherapy or in combination with nivolumab or pembrolizumab in HLA-A2+ patients with MAGE-A4-positive tumo…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors [Phase 1]
Pfizer's Phase 1 study PF-08046876 is recruiting adults with various advanced solid tumors to evaluate safety and dosing. The trial includes…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric [NA]
Update on the POP-UP trial, a single-arm, two-cohort study evaluating an 8-week trimodal prehabilitation program for patients with pancreati…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique
Ongoing longitudinal clinical trial evaluating evolution and factors influencing postoperative reflux after esophageal cancer surgery using …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation [NA]
This entry provides a feasibility study update on magnetic sentinel lymph node mapping for upper gastrointestinal cancers, focusing on gastr…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06) [Phase 1, Phase 2]
This document describes Substudy 06D of a Phase 1/2 clinical trial evaluating pembrolizumab in combination therapies for second-line gastroe…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy [NA]
A clinical trial update describing a symptom management program guided by patient-reported outcomes after esophagectomy for esophageal cance…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]
Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Mayo Clinic Upper Digestive Disease Survey
A Mayo Clinic study is currently recruiting for an upper digestive disease survey focused on esophageal neoplasms and esophageal cancer.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: To Observe the Benefit of Adding Brachytherapy After CCRT on Resectable Esophageal Cancer Patients Without Surgery [NA]
This clinical trial investigates whether adding brachytherapy after concurrent chemoradiotherapy improves outcomes for resectable esophageal…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)
Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for mu…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Balloon Dilation in Patients Undergoing Minimally Invasive Ivor Lewis Esophagectomy and Its Effect on Reducing DGCE [NA]
A clinical trial evaluating balloon dilation to reduce delayed gastric conduit emptying after minimally invasive Ivor Lewis esophagectomy; t…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Multimodal Deep Learning for Predicting Treatment Response to Neoadjuvant Chemoimmunotherapy in Esophageal Cancer
A clinical trial update describes a study employing multimodal deep learning to predict treatment response to neoadjuvant chemoimmunotherapy…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer [Phase 1]
Phase 1 clinical trial evaluating nivolumab with or without relatlimab before chemoradiation in patients with gastric or esophageal cancers;…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body [Phase 3]
A Phase 3 trial is evaluating whether adding radiotherapy to standard chemotherapy improves outcomes for patients with metastatic esophageal…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring [NA]
This multicenter prospective trial is evaluating whether adding concurrent chemoradiotherapy after induction immunochemotherapy improves out…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 first-in-human study of IPH5301, an anti-CD73 antibody, given alone or with chemotherapy and trastuzumab, in patients with advance…